Use the scheduling tool below to browse all the available sessions, speakers and topics at this year's event. Find the content and sessions to fit all of your educational needs and ensure you get the most out of your time at the show.
Dr. Nelson, TissueGen's Founder and Chief Scientific Officer, received his Ph.D. from The University of Texas Southwestern Medical Center at Dallas under the direction of Dr. Robert Eberhart. As a faculty member in Biomedical Engineering at the University of Texas at Arlington in 1996, he joined a team working on an NIH grant to develop a fiber-based, bioresorbable vascular stent with the goal of delivering gene therapy to the vessel wall. Simultaneously working with Dr. Nathan Schwade to develop drug-loaded microspheres for improved wound healing, he eventually combined the drug-loading techniques of microspheres with the fiber for the bioresorbable stent, and fiber-based drug delivery was born. Now patented, this technology has been the focus of Dr. Nelson's professional life and the driver behind TissueGen.